Rohto Pharmaceutical Co., Ltd. (RPHCF)
Market Open
10 Aug, 20:00
OTC PINK 
$
15. 00
0
0%
$
3.43B Market Cap
- P/E Ratio
0.27% Div Yield
150 Volume
- Eps
$ 15
Previous Close Want to track RPHCF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 0.25 | - |
| | | 39.89 | - |
| | | - | 24.76 |
| | | - | 12.07 |
| | | - | 11.35 |
| | | - | 0.1 |
| | | 25.07 | 31.19 |
| | | - | 0.26 |
| | | 25.72 | 24.51 |
| | | - | 0.2 |
| | | 26.32 | 25.82 |
| | | - | 0.23 |
| | | - | 0.06 |
| | | - | 0.06 |
| | | - | 0.3 |
| | | - | 0.22 |
| | | - | 0.16 |
| | | - | 0.09 |
RPHCF Earnings Reports FAQ
What is the earnings per share (EPS) for RPHCF?
EPS data for RPHCF is currently not available, as Rohto Pharmaceutical Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately 551.35%, reflecting the RPHCF's performance and OTC PINK market conditions.
When is the next earnings release date?
Rohto Pharmaceutical Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Rohto Pharmaceutical Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RPHCF at this time, as Rohto Pharmaceutical Co., Ltd has no recent EPS data to calculate it.
